Characterization of Symptom Bother and Health-related Quality of Life in Japanese Female Patients With Overactive Bladder

被引:11
|
作者
Gotoh, Momokazu [1 ]
Kobayashi, Toshimitsu [2 ]
Sogabe, Keizo [2 ]
机构
[1] Nagoya Univ, Grad Sch Med, Dept Urol, Nagoya, Aichi 4668550, Japan
[2] Astellas Pharma Inc, Med Affairs, Tokyo, Japan
关键词
multiple regression analysis; OAB-q; OABSS; symptom severity; URINARY-TRACT SYMPTOMS; DOUBLE-BLIND; SOLIFENACIN; IMPACT; OAB; QUESTIONNAIRE; INCONTINENCE;
D O I
10.1002/nau.22663
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aims: To analyze the impact of overactive bladder (OAB) symptoms and patient characteristics on symptom bother and quality of life (QOL). Methods: An analysis of the data of 967 patients from SET-Q, a prospective, multicenter, open, observational study in the post-marketing setting, was performed. The eligible subjects were treatment-naive female patients with OAB who complained of an urgency episode at least once a week. Symptom bother and QOL were assessed by the OAB-questionnaire (OAB-q), and severity of OAB symptoms was estimated by the OAB symptom score (OABSS). Multiple regression analysis was utilized for clarifying how OAB symptom severity affects QOL. Results: The symptoms with the highest bother score were daytime frequency and urgency in the under-50s age group, urgency in the 50s, 60s, and 70s age groups, night-time frequency and urgency incontinence in the over-80s age group, respectively. With an increase in severity of OAB as well as severity of urgency assessed by the OABSS, an increase in symptom bother and impairment in health-related quality of life (HRQL) in the OAB-q were observed. Multiple regression analysis demonstrated the significant relationship with urgency and nighttime frequency to symptom bother, and also significant interaction between age and urgency incontinence, associated with further negative effect on HRQLs in elderly patients. Conclusions: This large sample study, by utilizing the scored questionnaire for symptom severity, bother and HRQL, showed that the symptoms with the highest bother were age-dependent. It was also confirmed that symptom bother will be inferred by the OABSS. Neurourol. Urodynam. 34:730-735, 2015. (c) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:730 / 735
页数:6
相关论文
共 50 条
  • [1] CHARACTERIZATION OF SYMPTOM BOTHER, HEALTH-RELATED QUALITY OF LIFE, AND PATIENT'S SATISFACTION TO BLADDER CONDITION IN 967 JAPANESE FEMALE PATIENTS WITH OVERACTIVE BLADDER
    Gotoh, M.
    Kobayashi, T.
    Sogabe, K.
    [J]. NEUROUROLOGY AND URODYNAMICS, 2013, 32 (06) : 851 - 852
  • [2] Solifenacin for overactive bladder with incontinence: Symptom bother and health-related quality of life outcomes
    Garely, Alan D.
    Lucente, Vincent
    Vapnek, Jonathan
    Smith, Neila
    [J]. ANNALS OF PHARMACOTHERAPY, 2007, 41 (03) : 391 - 399
  • [3] Overactive bladder symptom bother and health-related quality of life in patients with systemic lupus erythematosus and primary Sjogren syndrome
    Pereira e Silva, R.
    Romao, V. C.
    Neves, M.
    Garcia, R.
    Oliveira, S.
    Brites, J.
    Oliveira Ramos, F.
    Canhao, H.
    Palma dos Reis, J.
    Pereira da Silva, J. A.
    Lopes, T.
    [J]. LUPUS, 2019, 28 (01) : 27 - 33
  • [4] Health-related quality of life in patients with overactive bladder
    Dmochowski, R.
    Mehnert, U.
    Sussman, D. O.
    MacDiarmid, S.
    Globe, D.
    Signori, M.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E579 - U244
  • [5] Relationships between symptoms, symptom bother, and health-related quality of life in patients with overactive bladder taking solifenacin or placebo in the VIBRANT study
    Crosby, R. D.
    Mathias, S. D.
    Marshall, T. S.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2011, 65 (02) : 211 - 218
  • [6] Relationships between improvements in symptoms and patient assessments of bladder condition, symptom bother and health-related quality of life in patients with overactive bladder treated with tolterodine
    Coyne, K. S.
    Elinoff, V.
    Gordon, D. A.
    Deng, D. Y.
    Brodsky, M.
    Glasser, D. B.
    Jumadilova, Z.
    Carlsson, M.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2008, 62 (06) : 925 - 931
  • [7] IMPACT OF SOLIFENACIN ON SYMPTOM BOTHER, HEALTH-RELATED QUALITY OF LIFE, WORK PRODUCTIVITY, TREATMENT SATISFACTION, AND SYMPTOMS IN PATIENTS WITH OVERACTIVE BLADDER: RESULTS FROM VIBRANT
    Mitcheson, H. D.
    Roy, J. B.
    Gilmet, G.
    Marshall, T. S.
    Shannon, J. B.
    [J]. VALUE IN HEALTH, 2009, 12 (03) : A201 - A201
  • [8] Correlation Between Improvements in Overactive Bladder Symptom Score and Health-Related Quality of Life Questionnaires in Overactive Bladder Patients Treated With an Antimuscarinic Drug
    Kubota, Yasue
    Kojima, Yoshiyuki
    Shibata, Yasuhiro
    Imura, Makoto
    Kohri, Kenjiro
    Sasaki, Shoichi
    [J]. NEUROUROLOGY AND URODYNAMICS, 2011, 30 (07) : 1309 - 1314
  • [9] Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: The VESIcare Open-Label Trial (VOLT)
    Garely, Alan D.
    Kaufman, Joel M.
    Sand, Peter K.
    Smith, Nella
    Andoh, Masakazu
    [J]. CLINICAL THERAPEUTICS, 2006, 28 (11) : 1935 - 1946
  • [10] DEVELOPMENT OF THE OVERACTIVE BLADDER QUESTIONNAIRE SHORT FORM (OAB-Q SF): A BRIEF MEASURE OF SYMPTOM BOTHER AND HEALTH-RELATED QUALITY OF LIFE
    Coyne, K.
    Lai, J. S.
    Matza, L.
    Zyczynski, T.
    Kopp, Z.
    Abrams, P.
    [J]. QUALITY OF LIFE RESEARCH, 2004, 13 (09) : 1549 - 1549